| Development of an adenovirus vector lacking the expression of virus-associated RNAs. | |
| | |
MedLine Citation:
|
PMID: 21703313 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
A major limitation of the use of adenovirus (Ad) vectors is the innate immune response, which causes inflammatory cytokine production and tissue damages. To overcome this limitation, it is necessary to develop safer Ad vectors that are less likely to induce innate immunity. The Ad genome encodes two non-coding small RNAs, virus-associated (VA)-RNA I and VA-RNA II, which are transcribed by RNA polymerase III and promote Ad replication. Recently, we reported that VA-RNAs are produced in the cells transduced with a conventional first-generation (E1-deleted) Ad vector (FG-Ad) and trigger innate immune responses through intracellular nucleic acid sensors. In the present study, we have developed a VA-RNA-deleted Ad (AdΔVR) vector, in which the transcriptional control elements of the VA-RNA-expression were deleted. Although conventional HEK293 cells did not support the propagation of the AdΔVR vectors, HEK293 transformants inducibly expressing VA-RNA I (VR293 cells) with appropriate induction of VA-RNA I expression allowed the propagation of the AdΔVR vector. The AdΔVR vector showed high transduction efficiency comparable to that of the conventional FG-Ad vector in the cultured cells. The AdΔVR vector may be a safer alternative to the FG-Ad vector. |
| | |
Authors:
|
Mitsuhiro Machitani; Kazufumi Katayama; Fuminori Sakurai; Hayato Matsui; Tomoko Yamaguchi; Takayuki Suzuki; Hiroyuki Miyoshi; Kenji Kawabata; Hiroyuki Mizuguchi |
Related Documents
:
|
11177773 - Apoptosis and rheumatoid arthritis: past, present, and future directions. 21374063 - A role of the aryl hydrocarbon receptor in attenuation of colitis. 18771733 - Differential effects of usp14 and uch-l1 on the ubiquitin proteasome system and synapti... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-16 |
Journal Detail:
|
Title: Journal of controlled release : official journal of the Controlled Release Society Volume: - ISSN: 1873-4995 ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8607908 Medline TA: J Control Release Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011. Published by Elsevier B.V. |
Affiliation:
|
Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6, Yamadaoka, Suita, Osaka, 565-0871, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: High-throughput DNA isolation method for detection of Xylella fastidiosa in plant and insect samples...
Next Document: Situation-specific cognitive behavioural self-therapy for erroneously suspected allergy or intoleran...